343 related articles for article (PubMed ID: 28985507)
21. Programmable CRISPR-Cas transcriptional activation in bacteria.
Ho HI; Fang JR; Cheung J; Wang HH
Mol Syst Biol; 2020 Jul; 16(7):e9427. PubMed ID: 32657546
[TBL] [Abstract][Full Text] [Related]
22. Large-scale multiplexed mosaic CRISPR perturbation in the whole organism.
Liu B; Jing Z; Zhang X; Chen Y; Mao S; Kaundal R; Zou Y; Wei G; Zang Y; Wang X; Lin W; Di M; Sun Y; Chen Q; Li Y; Xia J; Sun J; Lin CP; Huang X; Chi T
Cell; 2022 Aug; 185(16):3008-3024.e16. PubMed ID: 35870449
[TBL] [Abstract][Full Text] [Related]
23. Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas.
Farzadfard F; Perli SD; Lu TK
ACS Synth Biol; 2013 Oct; 2(10):604-13. PubMed ID: 23977949
[TBL] [Abstract][Full Text] [Related]
24. Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9.
Fu BXH; Smith JD; Fuchs RT; Mabuchi M; Curcuru J; Robb GB; Fire AZ
Nat Microbiol; 2019 May; 4(5):888-897. PubMed ID: 30833733
[TBL] [Abstract][Full Text] [Related]
25. Bidirectional titration of yeast gene expression using a pooled CRISPR guide RNA approach.
Bowman EK; Deaner M; Cheng JF; Evans R; Oberortner E; Yoshikuni Y; Alper HS
Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18424-18430. PubMed ID: 32690674
[TBL] [Abstract][Full Text] [Related]
26. A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function.
Loo CS; Gatchalian J; Liang Y; Leblanc M; Xie M; Ho J; Venkatraghavan B; Hargreaves DC; Zheng Y
Immunity; 2020 Jul; 53(1):143-157.e8. PubMed ID: 32640256
[TBL] [Abstract][Full Text] [Related]
27. Dissecting Molecular Phenotypes Through FACS-Based Pooled CRISPR Screens.
Genolet O; Ravid Lustig L; Schulz EG
Methods Mol Biol; 2022; 2520():1-24. PubMed ID: 35218528
[TBL] [Abstract][Full Text] [Related]
28. High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.
Montalbano A; Canver MC; Sanjana NE
Mol Cell; 2017 Oct; 68(1):44-59. PubMed ID: 28985510
[TBL] [Abstract][Full Text] [Related]
29. CIGAR-seq, a CRISPR/Cas-based method for unbiased screening of novel mRNA modification regulators.
Fang L; Wang W; Li G; Zhang L; Li J; Gan D; Yang J; Tang Y; Ding Z; Zhang M; Zhang W; Deng D; Song Z; Zhu Q; Cui H; Hu Y; Chen W
Mol Syst Biol; 2020 Nov; 16(11):e10025. PubMed ID: 33251765
[TBL] [Abstract][Full Text] [Related]
30. Evaluating Capture Sequence Performance for Single-Cell CRISPR Activation Experiments.
Choo XY; Lim YM; Katwadi K; Yap L; Tryggvason K; Sun AX; Li S; Handoko L; Ouyang JF; Rackham OJL
ACS Synth Biol; 2021 Mar; 10(3):640-645. PubMed ID: 33625849
[TBL] [Abstract][Full Text] [Related]
31. Alpha-synuclein induces the unfolded protein response in Parkinson's disease SNCA triplication iPSC-derived neurons.
Heman-Ackah SM; Manzano R; Hoozemans JJM; Scheper W; Flynn R; Haerty W; Cowley SA; Bassett AR; Wood MJA
Hum Mol Genet; 2017 Nov; 26(22):4441-4450. PubMed ID: 28973645
[TBL] [Abstract][Full Text] [Related]
32. Computational Prediction of CRISPR/Cas9 Target Sites Reveals Potential Off-Target Risks in Human and Mouse.
Wang Q; Ui-Tei K
Methods Mol Biol; 2017; 1630():43-53. PubMed ID: 28643248
[TBL] [Abstract][Full Text] [Related]
33. Bridging high-throughput genetic and transcriptional data reveals cellular responses to alpha-synuclein toxicity.
Yeger-Lotem E; Riva L; Su LJ; Gitler AD; Cashikar AG; King OD; Auluck PK; Geddie ML; Valastyan JS; Karger DR; Lindquist S; Fraenkel E
Nat Genet; 2009 Mar; 41(3):316-23. PubMed ID: 19234470
[TBL] [Abstract][Full Text] [Related]
34. Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells.
Voets O; Tielen F; Elstak E; Benschop J; Grimbergen M; Stallen J; Janssen R; van Marle A; Essrich C
PLoS One; 2017; 12(8):e0182974. PubMed ID: 28800587
[TBL] [Abstract][Full Text] [Related]
35. mpCRISTAR: Multiple Plasmid Approach for CRISPR/Cas9 and TAR-Mediated Multiplexed Refactoring of Natural Product Biosynthetic Gene Clusters.
Kim H; Ji CH; Je HW; Kim JP; Kang HS
ACS Synth Biol; 2020 Jan; 9(1):175-180. PubMed ID: 31800222
[TBL] [Abstract][Full Text] [Related]
36. CRISPR-Cas-Mediated Chemical Control of Transcriptional Dynamics in Yeast.
Cunningham-Bryant D; Sun J; Fernandez B; Zalatan JG
Chembiochem; 2019 Jun; 20(12):1519-1523. PubMed ID: 30710419
[TBL] [Abstract][Full Text] [Related]
37. Rapid Assembly of gRNA Arrays via Modular Cloning in Yeast.
McCarty NS; Shaw WM; Ellis T; Ledesma-Amaro R
ACS Synth Biol; 2019 Apr; 8(4):906-910. PubMed ID: 30939239
[TBL] [Abstract][Full Text] [Related]
38. Unbiased Screens for Modifiers of Alpha-Synuclein Toxicity.
Höllerhage M; Bickle M; Höglinger GU
Curr Neurol Neurosci Rep; 2019 Feb; 19(2):8. PubMed ID: 30739256
[TBL] [Abstract][Full Text] [Related]
39. A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9.
Cui L; Vigouroux A; Rousset F; Varet H; Khanna V; Bikard D
Nat Commun; 2018 May; 9(1):1912. PubMed ID: 29765036
[TBL] [Abstract][Full Text] [Related]
40. Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy.
Chung CH; Allen AG; Atkins A; Link RW; Nonnemacher MR; Dampier W; Wigdahl B
Front Cell Infect Microbiol; 2021; 11():593077. PubMed ID: 33768011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
